{"id":5651,"date":"2014-11-26T21:52:32","date_gmt":"2014-11-26T20:52:32","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=5651"},"modified":"2014-11-26T21:52:32","modified_gmt":"2014-11-26T20:52:32","slug":"ims-health-prime-10-aziende-usano-i-social-media","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/ims-health-prime-10-aziende-usano-i-social-media\/","title":{"rendered":"IMS Health 2014: the top 10 companies that use Social Media"},"content":{"rendered":"<div id=\"spelling-correction\">IMS Health&#039;s 2014 Annual Social Media Report highlights that of the top 50 pharmaceutical companies globally, half do not engage with consumers, or patients, through social media on related health topics.<\/div>\n<p>IMS Health also ranks the top 10 pharmaceutical companies that use Social Media according to the following scheme:<\/p>\n<p><strong>1 \u2013 Johnson &amp; Johnson<\/strong><br \/>\n<strong>2 \u2013 GlaxoSmithkline<\/strong><br \/>\n<strong> 3 \u2013 Novo Nordisk<\/strong><br \/>\n<strong> 4 \u2013 Pfizer<\/strong><br \/>\n<strong> 5 \u2013 Novartis<\/strong><br \/>\n<strong> 6 \u2013 Boehringer Ingelheim<\/strong><br \/>\n<strong> 7 \u2013 Bayer<\/strong><br \/>\n<strong> 8 \u2013 Merck &amp; Co<\/strong><br \/>\n<strong> 9 \u2013 AstraZeneca<\/strong><br \/>\n<strong> 10 \u2013 UCB<\/strong><\/p>\n<p>IMS Health has used several indices to rank such companies as:<\/p>\n<p><strong>Achievement index:<\/strong>\u00a0 measures the absolute number of &#039;listeners&#039; and is based on the number of people each channel reaches through likes, shares and re-tweets.<\/p>\n<p><strong>Relevance index:<\/strong>\u00a0 measures whether people think messages, or content, are relevant and\/or useful. The index is based on the extent to which content is shared and transmitted across social networks.<\/p>\n<p><strong>Relationship index:<\/strong> it is a measure of interaction \u2013 back and forth of conversation \u2013 and a measure of the integration of consumers, or patients, with the pharmaceutical company. This index measures the level of interaction between a company and those who post, reply to or otherwise interact with company messages.<\/p>\n<p><strong>Johnson &amp; Johnson<\/strong> is the most social pharma company in the world, followed by GlaxoSmithKline and Pfizer.<br \/>\n<strong>Johnson &amp; Johnson<\/strong> is the most mentioned brand on social media.<br \/>\n<strong>Bayer<\/strong> has the most active base and highest number of fans on Facebook. As a result Bayer is ranked no. 1 on Facebook among all competitors.<br \/>\n<strong>Pfizer<\/strong> got the highest score on Twitter.<\/p>\n<p>Source: <a href=\"https:\/\/www.linkedin.com\/pulse\/article\/20141112031416-58679749-top-10-pharma-companies-using-social-media\" target=\"_blank\" rel=\"noopener\">Linked-in<span style=\"text-decoration: underline;\">\u00a0<\/span> <\/a>November 12, 2014<\/p>","protected":false},"excerpt":{"rendered":"<p>La relazione annuale di IMS Health sui Social Media del 2014, evidenzia che delle prime 50 aziende farmaceutiche a livello mondiale, la met\u00e0 non interagisce con i consumatori, o i pazienti, attraverso i Social Media su temi sanitari correlati. IMS Health classifica, inoltre, le prime 10 aziende farmaceutiche che utilizzano i Social Media secondo il &hellip;<\/p>","protected":false},"author":5,"featured_media":5657,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5651","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=5651"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5651\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/5657"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=5651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=5651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=5651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}